Humacyte, Inc. (HUMA) vs Spruce Biosciences, Inc. (SPRB)
- Humacyte, Inc. HUMA 0.43 −2.27%
- Spruce Biosciences, Inc. SPRB 39.65 −4.39%
Humacyte, Inc. and Spruce Biosciences, Inc. are both Biotechnology companies. Humacyte, Inc. and Spruce Biosciences, Inc. are of similar size ($122.1M and $119.2M). Humacyte, Inc. grew revenue faster over the last twelve months: 149.8% against −51.3%. Spruce Biosciences, Inc. has the higher net margin (0.00% vs −4,448.9%) and the higher return on invested capital (0.00% vs −433.7%). Across the 17 metrics below, Spruce Biosciences, Inc. leads on 13 and Humacyte, Inc. on 4.
Valuation
Profitability
| Metric | HUMA | SPRB | Biotechnology median |
|---|---|---|---|
| Gross margin | (494.58%) | 100.00% | 65.16% |
| Operating margin | (5,240.78%) | 0.00% | 0.00% |
| Net margin | (4,448.89%) | 0.00% | 0.00% |
| Free cash flow margin | (4,599.72%) | 0.00% | 0.00% |
| Return on equity | (534.42%) | (105.98%) | (56.36%) |
| Return on assets | (68.16%) | (82.38%) | (48.04%) |
| Return on invested capital | (433.66%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack